Key result
The wall-eclipsing sign distinguishes pulmonary artery sarcoma from pulmonary thromboembolism with ~85% prevalence.
Why the study?
Pulmonary artery sarcoma is a rare malignancy with a poor prognosis whose clinical manifestations and imaging findings are often indistinguishable from pulmonary thromboembolism.
Can clinical and imaging characteristics on CTPA and MRI accurately differentiate pulmonary artery sarcoma from pulmonary thromboembolism?
Case-Control (n=100)
No
Can clinical and imaging characteristics on CTPA and MRI accurately differentiate pulmonary artery sarcoma from pulmonary thromboembolism?
Specific CTPA and MRI features, such as the wall-eclipsing sign and expansive growth, combined with lower D-dimer levels, can help differentiate rare pulmonary artery sarcoma from pulmonary thromboembolism.
Answers are grounded in this paper and cite their sources.
Wall-eclipsing sign and aneurysm-like dilatation may aid differentiation of pulmonary artery sarcoma from thromboembolism; hypothesis-generating and requires prospective validation.
Background: Pulmonary artery sarcoma (PAS) is a very rare malignancy with a poor prognosis; however, its clinical manifestations and imaging findings are often indistinguishable from pulmonary thromboembolism (PTE). We thus aimed to accurately diagnose PAS by comparing the clinical and computed tomography pulmonary angiography (CTPA) and magnetic resonance imaging (MRI) imaging characteristics of PAS and PTE. Methods: This case-control study retrospectively enrolled 20 patients with PAS (from March 2017 to September 2022), 40 patients with central acute PTE, and 40 patients with central chronic PTE (from January 2021 to December 2022) in the China-Japan Friendship Hospital. The following clinical and imaging findings were compared between the three groups: initial symptoms; D-dimer, C-reactive protein, and N-terminal pro B-type natriuretic peptide levels; wall-eclipsing sign (WES); scope of lesion involvement; and morphological characteristics. Signal intensity was also observed on different MRI sequences. Results: The D-dimer level in PAS was significantly lower than that in central acute PTE (P<0.001). The WES was present in 17 cases of PAS (85.0%), which was a greater proportion than that of the central acute PTE and chronic PTE groups (all P values <0.001). The involvement of the pulmonary valve or right ventricular outflow tract was observed in five PAS cases but none of the central acute PTE or chronic PTE cases (all P values =0.001). In 19 PAS cases (95.0%), the lesions grew expansively in the central pulmonary artery. The proximal margin of 18 patients with PAS (90.0%) was bulging or lobulated. Nine cases of PAS (45.0%) showed aneurysm-like dilatation (grape-like sign) of the distal pulmonary artery, representing significantly greater proportion than that of the central acute PTE and chronic PTE groups (all P values <0.001). In 37 patients with central acute PTE (92.5%), the clots were observed to be floating in the pulmonary artery lumen with saddle, tubular or polypoid shape. Eccentric filling defects attached to the pulmonary artery wall were observed in 32 cases of central chronic PTE (80.0%). On MRI, PAS lesions were hyperintense on fat-suppressed T2-weighted imaging and diffusion-weighted imaging, demonstrating heterogeneous enhancement. Conclusions: Comprehensive analysis of the clinical data and imaging features on CTPA and MRI can aid in the accurate differential diagnosis of PAS and PTE.
No takes yet. Share an insight, caveat, or question.
Guo et al. (2024) conducted a case-control in Pulmonary artery sarcoma and pulmonary thromboembolism (n=100). Pulmonary artery sarcoma vs. Pulmonary thromboembolism was evaluated on Presence of wall-eclipsing sign (WES) (p=<0.001). Pulmonary artery sarcoma was distinguished from pulmonary thromboembolism by a higher prevalence of the wall-eclipsing sign and aneurysm-like dilatation.
Synapse has enriched 10 related papers. Consider them for comparative context: